| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Melani Kenneth R. | 18% | -35% | $9,843,685 | -$227,250 | 3,248,741 | -2.3% | Melani Kenneth R. | 30 Jun 2025 |
| Raju Ajay | 17% | $8,120,000 | 2,000,000 | Ajay Raju | 31 Dec 2024 | |||
| Bokhari Raza | 4.8% | -46% | $2,375,437 | +$316,875 | 1,218,173 | +15% | Bokhari Raza | 31 Dec 2025 |
| ARMISTICE CAPITAL, LLC | 5% | -49% | $2,835,244 | -$1,000,736 | 935,724 | -26% | Armistice Capital, LLC | 30 Jun 2025 |
| Hathaway John Jason | 4.5% | -33% | $2,426,885 | 800,952 | 0% | John Hathaway | 30 Jun 2025 |
As of 30 Sep 2025, 20 institutional investors reported holding 2,119,467 shares of Medicus Pharma Ltd. - Common shares, no par value (MDCX). This represents 8.4% of the company’s total 25,378,604 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 20,349 | $31,134 | -$28,722 | $1.53 | 2 |
| 2025 Q3 | 2,119,467 | $4,905,211 | -$365,331 | $2.32 | 20 |
| 2025 Q2 | 2,206,052 | $6,595,875 | -$3,790,457 | $2.99 | 21 |
| 2025 Q1 | 3,051,629 | $11,352,061 | +$5,738,203 | $3.72 | 7 |
| 2024 Q4 | 1,503,368 | $3,741,062 | +$3,741,062 | $2.46 | 3 |